Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Maxillary Sinusitis
Interventions
DRUG

Azithromycin SR

Azithromycin SR, 2.0 g by mouth (PO) x 1

DRUG

Amoxiclav 1000 mg

Amoxiclav 1000 mg x twice daily, 10 days

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY